Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats

Yuki Shigemoto, Kazuaki Shinomiya, Mitsunobu Mio, Nobuhide Azuma, Chiaki Kamei

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The present study was performed to examine the sedative effects of second-generation histamine H1 receptor antagonist using power spectrum analysis in the rat. Similar to ketotifen, olopatadine caused a decrease in sleep latency at a dose of 50 mg/kg, while epinastine and cetirizine showed no significant effect even at a dose of 50 mg/kg. On the other hand, no significant difference was observed in the total times of wakefulness, non-rapid eye movement sleep and rapid eye movement sleep by any drugs used in the experiments. The number of sleep phases and interval between sleep phases were also unchanged by these drugs. Ketotifen and olopatadine inhibited [ 3H]mepyramine binding to rat brain homogenates in parallel with a decrease in sleep latency. No significant effect was observed with epinastine and cetirizine on [3H]mepyramine binding. These findings suggest that the differences in the central nervous system (CNS) depressant effect observed in second generation H1 receptor antagonists may be due to their liability to penetrate into the CNS.

Original languageEnglish
Pages (from-to)161-165
Number of pages5
JournalEuropean Journal of Pharmacology
Volume494
Issue number2-3
DOIs
Publication statusPublished - Jun 28 2004

Fingerprint

Histamine H1 Antagonists
Cohort Effect
Wakefulness
Sleep
Cetirizine
Ketotifen
Pyrilamine
Non-Sedating Histamine H1 Antagonists
Central Nervous System Depressants
Histamine H1 Receptors
REM Sleep
Eye Movements
Hypnotics and Sedatives
Pharmaceutical Preparations
Spectrum Analysis
Central Nervous System
Brain

Keywords

  • Binding assay
  • Ketotifen
  • Rat
  • Second-generation histamine H receptor antagonists
  • Sleep-wakefulness cycle

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats. / Shigemoto, Yuki; Shinomiya, Kazuaki; Mio, Mitsunobu; Azuma, Nobuhide; Kamei, Chiaki.

In: European Journal of Pharmacology, Vol. 494, No. 2-3, 28.06.2004, p. 161-165.

Research output: Contribution to journalArticle

Shigemoto, Yuki ; Shinomiya, Kazuaki ; Mio, Mitsunobu ; Azuma, Nobuhide ; Kamei, Chiaki. / Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats. In: European Journal of Pharmacology. 2004 ; Vol. 494, No. 2-3. pp. 161-165.
@article{0717d1702b3740b3a78888d5a72480a6,
title = "Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats",
abstract = "The present study was performed to examine the sedative effects of second-generation histamine H1 receptor antagonist using power spectrum analysis in the rat. Similar to ketotifen, olopatadine caused a decrease in sleep latency at a dose of 50 mg/kg, while epinastine and cetirizine showed no significant effect even at a dose of 50 mg/kg. On the other hand, no significant difference was observed in the total times of wakefulness, non-rapid eye movement sleep and rapid eye movement sleep by any drugs used in the experiments. The number of sleep phases and interval between sleep phases were also unchanged by these drugs. Ketotifen and olopatadine inhibited [ 3H]mepyramine binding to rat brain homogenates in parallel with a decrease in sleep latency. No significant effect was observed with epinastine and cetirizine on [3H]mepyramine binding. These findings suggest that the differences in the central nervous system (CNS) depressant effect observed in second generation H1 receptor antagonists may be due to their liability to penetrate into the CNS.",
keywords = "Binding assay, Ketotifen, Rat, Second-generation histamine H receptor antagonists, Sleep-wakefulness cycle",
author = "Yuki Shigemoto and Kazuaki Shinomiya and Mitsunobu Mio and Nobuhide Azuma and Chiaki Kamei",
year = "2004",
month = "6",
day = "28",
doi = "10.1016/j.ejphar.2004.05.010",
language = "English",
volume = "494",
pages = "161--165",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats

AU - Shigemoto, Yuki

AU - Shinomiya, Kazuaki

AU - Mio, Mitsunobu

AU - Azuma, Nobuhide

AU - Kamei, Chiaki

PY - 2004/6/28

Y1 - 2004/6/28

N2 - The present study was performed to examine the sedative effects of second-generation histamine H1 receptor antagonist using power spectrum analysis in the rat. Similar to ketotifen, olopatadine caused a decrease in sleep latency at a dose of 50 mg/kg, while epinastine and cetirizine showed no significant effect even at a dose of 50 mg/kg. On the other hand, no significant difference was observed in the total times of wakefulness, non-rapid eye movement sleep and rapid eye movement sleep by any drugs used in the experiments. The number of sleep phases and interval between sleep phases were also unchanged by these drugs. Ketotifen and olopatadine inhibited [ 3H]mepyramine binding to rat brain homogenates in parallel with a decrease in sleep latency. No significant effect was observed with epinastine and cetirizine on [3H]mepyramine binding. These findings suggest that the differences in the central nervous system (CNS) depressant effect observed in second generation H1 receptor antagonists may be due to their liability to penetrate into the CNS.

AB - The present study was performed to examine the sedative effects of second-generation histamine H1 receptor antagonist using power spectrum analysis in the rat. Similar to ketotifen, olopatadine caused a decrease in sleep latency at a dose of 50 mg/kg, while epinastine and cetirizine showed no significant effect even at a dose of 50 mg/kg. On the other hand, no significant difference was observed in the total times of wakefulness, non-rapid eye movement sleep and rapid eye movement sleep by any drugs used in the experiments. The number of sleep phases and interval between sleep phases were also unchanged by these drugs. Ketotifen and olopatadine inhibited [ 3H]mepyramine binding to rat brain homogenates in parallel with a decrease in sleep latency. No significant effect was observed with epinastine and cetirizine on [3H]mepyramine binding. These findings suggest that the differences in the central nervous system (CNS) depressant effect observed in second generation H1 receptor antagonists may be due to their liability to penetrate into the CNS.

KW - Binding assay

KW - Ketotifen

KW - Rat

KW - Second-generation histamine H receptor antagonists

KW - Sleep-wakefulness cycle

UR - http://www.scopus.com/inward/record.url?scp=3042531795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042531795&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2004.05.010

DO - 10.1016/j.ejphar.2004.05.010

M3 - Article

C2 - 15212970

AN - SCOPUS:3042531795

VL - 494

SP - 161

EP - 165

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -